Literature DB >> 18719998

Relation of matrix metalloproteinase-9 to different stages of tumors in the serum of gastric cancer.

V Dragutinović1, L Izrael-Zivković, N Radovanović.   

Abstract

The sera of 40 patients with gastric cancer and 11 patients as the control group were studied for the detection of matrix metalloproteinases. The malignant behavior of tumor cells mainly depends on the capability of invasion and the metastasis of cancer cells. After the components of the extracellular matrix (ECM) are degraded, tumor cells invade the surrounding tissue and the vascular or lymphatic vessels to form metastasis colonies at distant sites. Extracellular proteolytic enzymes implicate the invasion and metastasis of cancer. Proteolytic enzymes from tumors lead to the breakdown of basement membranes and the ECM, thereby, facilitating cancer cell invasion into the surrounding normal tissue. Proteinase activity is overexpressed in the serum of stage 3 and 4 tumors compared to stage 1 and 2 tumors. ProMMP-9 was detected in the serum of patients of gastric cancer by SDS polyacrylamide gel electrophoresis (SDS-PAGE) and SDS-PAGE zymography, with its molecular mass of 92 kDa. MMP-9 in serum plays an important role in the progression of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719998     DOI: 10.1007/s10620-008-0472-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

2.  Plasma concentration of matrix metalloproteinase 9 in gastric cancer.

Authors:  A Torii; Y Kodera; K Uesaka; T Hirai; K Yasui; T Morimoto; Y Yamamura; T Kato; T Hayakawa; N Fujimoto; T Kito
Journal:  Br J Surg       Date:  1997-01       Impact factor: 6.939

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Molecular aspects of tumor cell invasion and metastasis.

Authors:  S Aznavoorian; A N Murphy; W G Stetler-Stevenson; L A Liotta
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

5.  Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.

Authors:  Chun-Ying Wu; Ming-Shiang Wu; En-Pei Chiang; Yi-Ju Chen; Chien-Jen Chen; Nai-Hui Chi; Ying-Ting Shih; Gran-Hum Chen; Jaw-Town Lin
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

6.  Serum matrix metalloproteinase-9 level associated with stromal reaction in patients with gastric cancer.

Authors:  K H Shen; C W Chi; S S Lo; H L Kao; W Y Lui; C W Wu
Journal:  Anticancer Res       Date:  2000 Mar-Apr       Impact factor: 2.480

7.  Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma.

Authors:  Raquel F Gerlach; Caroline Demacq; Klaus Jung; Jose E Tanus-Santos
Journal:  Clin Biochem       Date:  2006-10-19       Impact factor: 3.281

8.  Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma.

Authors:  Michael W Kattan; Martin S Karpeh; Madhu Mazumdar; Murray F Brennan
Journal:  J Clin Oncol       Date:  2003-10-01       Impact factor: 44.544

9.  Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

Authors:  C F Sier; F J Kubben; S Ganesh; M M Heerding; G Griffioen; R Hanemaaijer; J H van Krieken; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

10.  Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer.

Authors:  F J G M Kubben; C F M Sier; W van Duijn; G Griffioen; R Hanemaaijer; C J H van de Velde; J H J M van Krieken; C B H W Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  2006-04-10       Impact factor: 7.640

View more
  11 in total

1.  Serum and biliary MMP-9 and TIMP-1 concentrations in the diagnosis of cholangiocarcinoma.

Authors:  Ali Tüzün İnce; Kemal Yıldız; Venkatanarayana Gangarapu; Yusuf Kayar; Birol Baysal; Oğuzhan Karatepe; Ahu Sarbay Kemik; Hakan Şentürk
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Prognostic and clinical significance of STAT3 and MMP9 in patients with gastric cancer: a meta-analysis of a Chinese cohort.

Authors:  Jing Chen; Xiaoxia Liu; Haiyan Jiao; Liang Peng; Zhenghao Huo; Wenjun Yang; Qin Shen; Tao Li; Qilun Liu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Significance of elevated levels of collagen type IV and hyaluronic acid in gastric juice and serum in gastric cancer and precancerous lesion.

Authors:  Hai-Ling Ruan; Ru-Tao Hong; Hui-Jun Xie; Nai-Zhong Hu; Jian-Ming Xu; Wei Zhang
Journal:  Dig Dis Sci       Date:  2011-01-25       Impact factor: 3.199

4.  Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer.

Authors:  Sunmi Park; Mark C Willingham; Jun Qi; Sheue-Yann Cheng
Journal:  Endocr Relat Cancer       Date:  2018-06-18       Impact factor: 5.678

5.  Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.

Authors:  Vesna V Dragutinović; Nevena V Radonjić; Nataša D Petronijević; Svetislav B Tatić; Ivan B Dimitrijević; Nebojša S Radovanović; Zoran V Krivokapić
Journal:  Mol Cell Biochem       Date:  2011-05-04       Impact factor: 3.396

6.  Body fluid MMP-2 as a putative biomarker in metastatic breast cancer.

Authors:  Sewon Noh; Jae-Joon Jung; Minkyu Jung; Ki-Hyang Kim; Ha-Young Lee; Brandon Wang; Joanna Cho; Tae Soo Kim; Hei-Cheul Jeung; Sun Young Rha
Journal:  Oncol Lett       Date:  2012-01-03       Impact factor: 2.967

7.  Pre-treatment gelatinases' serum levels and post-treatment changes in laryngeal cancer patients.

Authors:  G Tsiropoulos; T Papadas; Ie Triantaphyllidou; S Naxakis; K Markou; S Triaridis; I Vital; P Goumas; Dh Vynios
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

8.  Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.

Authors:  S Wilson; S Damery; D D Stocken; G Dowswell; R Holder; S T Ward; V Redman; M J Wakelam; J James; F D R Hobbs; T Ismail
Journal:  Br J Cancer       Date:  2012-03-20       Impact factor: 7.640

9.  Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.

Authors:  Kawin Leelawat; Sompong Sakchinabut; Siriluck Narong; Jerasak Wannaprasert
Journal:  BMC Gastroenterol       Date:  2009-04-30       Impact factor: 3.067

10.  Expression and correlation of Twist and gelatinases in breast cancer.

Authors:  Min Zhao; Hong-Guang Hu; Jin Huang; Qiang Zou; Jin Wang; Ming-Qiang Liu; Yang Zhao; Gui-Zhu Li; Song Xue; Zheng-Sheng Wu
Journal:  Exp Ther Med       Date:  2013-05-02       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.